Argyle Capital Management Inc. Viatris Inc Transaction History
Argyle Capital Management Inc.
- $248 Million
- Q3 2024
A detailed history of Argyle Capital Management Inc. transactions in Viatris Inc stock. As of the latest transaction made, Argyle Capital Management Inc. holds 10,217 shares of VTRS stock, worth $115,452. This represents 0.05% of its overall portfolio holdings.
Number of Shares
10,217
Previous 10,655
4.11%
Holding current value
$115,452
Previous $113,000
4.42%
% of portfolio
0.05%
Previous 0.05%
Shares
15 transactions
Others Institutions Holding VTRS
# of Institutions
1,095Shares Held
930MCall Options Held
2.69MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA141MShares$1.59 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.05 Billion0.02% of portfolio
-
State Street Corp Boston, MA63.1MShares$713 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$708 Million4.18% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD48.8MShares$551 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13.7B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...